CVRx, Inc.

NASDAQ:CVRX

Medical - Devices

Healthcare
$2.63 +2.28%

+$0.11 today

Market cap
$69.79M
Beta
0.77
P/E (TTM)
-2.5
EPS (TTM)
-$2.00
52W Low $4.37High $11.30

Volume 0.37M

Average 0.30M

CVRX Total Debt

Short-term and long-term borrowings combined.

CVRx, Inc.NASDAQ: CVRX

Total Debt · Q1 FY2026 · quarter ended Mar 2026

Total debt rises 17.8% from a year ago

Total debt stood at $59.4M at the end of Q1 FY2026, up 17.8% from a year earlier and up 16.9% from the prior quarter. Over 3 fiscal years it compounded at +92.8% a year.

Context

  • Total debt amounted to 59.6% of total assets at the end of Q1 FY2026, up 20.6 pp from a year earlier.
  • Total debt increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total debt keeps rising in the next quarterly balance sheet after a +17.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$59.4M+16.9% QoQ
Last fiscal yearDec 2025
$50.79M+0.7% YoY
Year agoMar 2025
$50.42M+17.8% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+17.8%——
1 year+0.7%——
3-year CAGR+92.8%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
50.79M USD
Year-over-year change
+0.7%

Total Debt vs competitors

How CVRX compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +17.8% is the 3rd highest of 10, against a peer median of +3.2%.
  • Total debt amounts to 59.6% of total assets for CVRX, versus a peer median of 13.8%.
CVRX Competitors
Total Debt for CVRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CERSCerus CorporationMar 2026$97.36M USD-2.1%+3.6%43.7%
CVRXCVRx, Inc.Mar 2026$59.4M USD+17.8%+92.8%59.6%
SENSSenseonics Holdings, Inc.Mar 2026$43.14M USD+5.0%-18.1%41.9%
SGHTSight Sciences, Inc.Mar 2026$41.76M USD+3.2%+5.2%38.1%
QTRXQuanterix CorporationMar 2026$35.34M USD-2.9%-5.5%9.6%
SNWVSANUWAVE Health, Inc.Mar 2026$22.16M USD-17.5%-16.2%59.7%
PRQRProQR Therapeutics N.V.Mar 2026€13.7M EUR-16.0%-14.0%13.8%
VMDViemed Healthcare, Inc.Mar 2026$12.44M USD+84.0%+184.3%6.3%
NNOXNano-X Imaging Ltd.Dec 2025$7.85M USD+5.4%+19.3%4.8%
MASS908 Devices Inc.Mar 2026$4.47M USD+18.6%-5.0%2.4%
Peer median (excluding CVRX) —+3.2%-5.0%13.8%

Competitors are the stored peer set for CVRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents142.07M106.19M90.57M105.93M75.71M
Short-term Investments00000
Net Receivables2.56M5.5M7.55M9.27M10.67M
Inventory3.88M6.96M10.98M12.11M12.21M
Other Current Assets2.59M4.22M2.99M2.51M3.07M
Total Current Assets151.1M122.88M112.09M129.81M101.65M
Property, Plant & Equipment (Net)1.43M2.03M3.11M3.57M3.12M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets26K27K27K27K26K
Total Non-current Assets1.45M2.06M3.14M3.6M3.15M
Total Assets152.55M124.94M115.23M133.41M104.79M
Account Payables510K1.72M1.88M2.58M3.83M
Short-term Debt00000
Tax Payables351K120K125K135K0
Deferred Revenue00000
Other Current Liabilities2.32M3.26M4.11M5.67M9.48M
Total Current Liabilities5.91M8.09M7.86M10.76M13.32M
Long-term Debt06.75M29.22M49.27M50.15M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities681K805K1.04M1.45M1.36M
Total Non-current Liabilities681K7.67M31.42M51.6M52.15M
Total Liabilities6.59M15.76M39.28M62.36M65.47M
Common Stock204K207K209K253K263K
Retained Earnings(394.75M)(436.18M)(477.38M)(537.35M)(590.65M)
Accumulated OCI(198K)(207K)(207K)(206K)(203K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity145.96M109.18M75.95M71.06M39.32M
Total Debt07.09M30.61M50.43M50.79M
Net Debt(142.07M)(99.11M)(59.96M)(55.5M)(24.92M)

CVRx, Inc.

NASDAQ:CVRX

Intrinsic Alpha fair value

Locked

Current Price

$2.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.